A long while ago (1995?) I was with Ian Morrison trying to sell something to an exec Mt Sinai Hospital in New York. Wondering by the exec’s office was Jack Rowe, lately of Aetna, but then the CEO of Mt Sinai. Ian was due to talk to their board; Jack noticed him and said something similar to, "don’t use your line about hospital CEO’s being overpaid facilities managers". It was half joking full serious.
Recently close to my neck of the woods there’s been a little fuss about salaries at El Camino Hospital–a district hospital in Mountain View, CA in the heart of Silicon Valley. (A district hospital is a weird California beast–basically a typical non-profit with some relatively minor tax support from the locale).
Back in the 1990s like many hospitals, El Camino was bleeding money. But the ship got righted. Now it makes a pretty decent profit with around $21m in income on something over $300m revenue. Still there was a big spat about whether or not the hospital (which does after all get some tax payer support) should tell the world about how much its CEO gets. Eventually they were forced to reveal all
El Camino Hospital’s chief executive officer earned a base salary of $492,291 in 2004, according to IRS Form 990, released by the hospital last week. In addition, CEO Lee Domanico received a bonus of $173,306, $9,000 in expenses and allowances and $249,127 in deferred compensation and contributions to his benefit plan. In 2002, the hospital lent the CEO $850,000 at 6 percent simple interest on a 10-year loan. Annual interest forgiveness is treated as additional compensation. In 2004, $19,380 in interest was forgiven.The typical salary of a CEO of an independent hospital with more than $200 million in annual revenue was $426,000 in 2004, according to Sullivan, Cotter and Associates, which prepared the comparison sheet the hospital released with the Form 990. The independent El Camino Hospital’s revenue is more than $300 million a year, Friedenberg said.
But actually it was rather more than that for the CEO, the scurrilous local rag the Mt View Voice reported
Tax documents released this week show El Camino Hospital CEO Lee Domanico received more than $900,000 in total compensation in the fiscal year ending June 30, and five other members of the hospital’s management team earned more than $300,000 during the period.
Compared to that the new guy, who starts Aug 7 but is going to have to scrape by:
Graham’s base salary is $543,000, which ranks him near the top of
his Bay Area counterparts. Washington Hospital in Fremont, also a
community district facility, pays CEO Nancy Farber a $424,557 base
salary. Domanico’s base was $500,000. Domanico’s contract also offered him a bonus of up to 40 to 45
percent of his base salary; Graham’s incentive pay will be capped at 30
percent of his base.
Now I know that living in Silicon Valley is expensive, but even so half a million bucks a year for running a community hospital seems like a pretty decent salary. Yet apparently they’re happy to believe that it’s par for the course–and it more or less is. USA Today had a piece on hospital CEO salaries a while back, but it really focused on the bigger non-profit systems which all pay a million or two. But there are roughly 2000 hospitals bigger than 200 beds but smaller than the giants. And if El Camino paying its execs that amount isn’t so out of line with other large community hospitals as their compensation excuse maker says–well perhaps running a hospital is just much harder than we cynics suppose it is. At any rate there are therefore some 2,000-ish CEOs making a prett decent whack.
Who knows, maybe the surgeons make the CEO pick up the tab.
figured out that the way to save the $2 trillion healthcare industry – it’s for people to not get sick by getting doctors out of medicine. After spending the last few years following doctors and radiologists around, visiting cancer centers and spending time watching mice get poked and prodded, I’ve realized it is time to embed the expertise of doctors in silicon and software. Why have radiologists read mammograms to find 1 in 200 that have breast cancer? Today, a third of mammograms now have their second read done by computer, computer aided detection from companies like R2 and iCad, and for $29, much less than a radiologist, and perhaps more accurate. For me, that’s just a start. But I was astounded to learn that CT scans are on the same learning curve as PCs and iPods and cell phones. One slice per rotation moved to 4 slice, 16 slice, 64 slice and soon 256 slice CT scanners. Instead of film, the output is a high res color 3D model. Beats a blood pressure reading and cholesterol number, which is all that physicians can manage. They are flying blind.So I started running the numbers. State of the art scans are still close to $1000. Say 1% of adults have heart attacks every year. A stent procedure runs about $15,000 just for the stent, with the hospital stay and bandaids, you are in for closer to $20-30,000, let alone lost wages and productivity. Heart scans today are around $1000. So if you screen 100 people, it costs $100,000, certainly more than treating the 1 in 100 heart attack patient. So,…, Blue Cross won’t pay for scans. It is better for them if nature does their screening for them, you or I actually having a heart attack – ding, ding, ding, we found our 1 in 100.They probably still wouldn’t pay if the scans were $500. But they might at $200. And they certainly would pay at $100, because it would be cheaper to screen than to pay for care. Because it is on the silicon learning curve (down 30% every year, 50% every two years), it is pretty easy to see $100 scans within five years, probably less. Heart attacks and stroke may become a thing of the past.And cancer, the third member of the Big Three in healthcare spending? Structural CT scans will transition to molecular imaging to find cancer early. I can see biomarkers on antibody chips that can eventually sell for $1 or maybe even 10 cents can detect unique cancer proteins in blood and flag cancer early enough for much cheaper treatment, beating symptoms by five years.Doctors can’t do that. In the end, I believe that Silicon Valley will do to doctors what ATMs did to tellers.
0.40; P values <.001) for all pairwise comparisons between
-blocker use at admission and discharge, aspirin use at admission and discharge, and angiotensin-converting enzyme inhibitor use, and weaker, but statistically significant, correlations between these medication measures and smoking cessation counseling and time to reperfusion therapy measures (correlation coefficients <0.40; P values <.001). Some process measures were significantly correlated with risk-standardized, 30-day mortality rates (P values <.001) but together explained only 6.0% of hospital-level variation in risk-standardized, 30-day mortality rates for patients with AMI.